CIRculating CANcer MAster-Protocol
ConditionAdult With Solid Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospices Civils de Lyon
About this trial
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Eligibility criteria
Qualifiers
Adult (>18y)
Owing a social security insurance
Any solid cancer diagnosed by histopathology or cytology
Patient with blood sampling required as per standard of care
Disqualifiers
Refusal to participate
No blood sampling required as per standard of care
Hemoglobin < 7g/dl (< 9g/dl if respiratory or cardiovascular disease history)
Heterologous blood transfusion in the last 48 hours
Trial design
Treatments tested in this trial
- Blood sampling for biomarker analysis (microRNA, circulating DNA…)
Treatment groups
6,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov